Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers

Vaccine

Volumn 31, Issue 24, 2013, Pages 2719-2722

  Kulkarni, Prasad S ^a   Sapru, Amita ^b   D'costa, Pradeep M ^b   Pandit, Anand ^b   Madhusudana, Shampur N ^c   Yajaman, Ashwin Belludi ^c   Mangrule, Somnath ^a   Gunale, Bhagwat ^a   Bavdekar, Ashish R ^b  

^a Cummins Research and Technology India Ltd   (India)

^b KEM HOSPITAL   (India)

^c NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Immunogenicity; Purified vero cell rabies vaccine; Rabies; Safety

Indexed keywords

PURIFIED VERO CELL RABIES VACCINE; RABIES VACCINE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTHRALGIA; ARTICLE; ASTHENIA; BLOOD CHEMISTRY; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; ELECTROCARDIOGRAM; ERYTHEMA; FAINTNESS; FEMALE; FEVER; HEADACHE; HEMATURIA; HUMAN; HYPERBILIRUBINEMIA; IMMUNE RESPONSE; IMMUNOGENICITY; INJECTION SITE INDURATION; INJECTION SITE PAIN; MALE; MYALGIA; NAUSEA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; PYURIA; RANDOMIZED CONTROLLED TRIAL; SHIVERING; THORAX RADIOGRAPHY; URINALYSIS; VACCINATION; VERO CELL;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; DEVELOPING COUNTRIES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; RABIES; RABIES VACCINES; RABIES VIRUS; VERO CELLS; YOUNG ADULT;

EID: 84878351535     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.03.050     Document Type: Article

References (13)

1. Knobel D.L., Cleaveland S., Coleman P.G., Fevre E.M., Meltzer M.I., Miranda M.E., et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 2005, 83(5):360-368.
2. WHO. Expert consultation on rabies: first report. Geneva, World Health Organization, 2005 (WHO Technical Report Series, No. 931;). http://whqlibdoc.who.int/trs/WHO_TRS_931_eng.pdf.
3. Rabies Vaccines WHO position paper. Wkly Epidemiol Rec 2010, 85(32):309-320. [August].
4. Sudarshan M.K., Madhusudana S.N., Mahendra B.J., et al. Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey. Int J Infect Dis 2007 Jan, 11(1):29-35.
5. Plotkin S.A. Vaccine production in human diploid cell strains. Am J Epidemiol 1971, 94(4):303-306.
6. Briggs D.J., Banzhoff A., Nicolay U., Sirikwin S., Dumavibhat B., Tongswas S., et al. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ 2000, 78:693-698.
7. Quiambao B.P., Dimaano E.M., Ambas C., Davis R., Banzhoff A., Malerczyk C. Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals. Vaccine 2005, 23:1709-1714.
8. [Accessed 09.07.12]. http://www.who.int/immunization_standards/vaccine_quality/Product_Insert_Rabipur_India_multilingual.pdf.
9. [Accessed 09.07.12]. http://www.who.int/immunization_standards/vaccine_quality/Rabipur_Product_Insert.pdf.
10. [Accessed 09.07.12]. http://www.who.int/immunization_standards/vaccine_quality/PQ_112_rabies_sanofi_PI_2010.pdf.
11. Ajjan N., Pilet C. Comparative study of the safety and protective value, in pre-exposure use, of rabies vaccine cultivated on human diploid cells (HDCV) and of the new vaccine grown on Vero cells. Vaccine 1989, 7:125-128.
12. Fishbein D.B., Dreesen D.W., Holmes D.F., Pacer R.E., Ley A.B., Yager P.A., et al. Human diploid cell rabies vaccine purified by zonal centrifugation: a controlled study of antibody response and side-effects following primary and booster pre-exposure immunizations. Vaccine 1989, 7:437-442.
13. Laothamatas J., Hemachudha T., Mitrabhakdi E., Wannakrairot P., Tulayadaechanont S. MR imaging in human rabies. Am J Neuroradiol 2003, 24:1102-1109.